Latest Information Update: 26 Feb 2010
At a glance
- Originator Esteve
- Mechanism of Action Opioid receptor agonists; Serotonin uptake stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 25 Jul 2001 Phase-I clinical trials for Pain (Unknown route)
- 04 Apr 2000 Preclinical development for Pain (Unknown route)